Published in Medical Letter on the CDC and FDA, July 31st, 2005
According to recent research from the United States, "CCR5 is the major co-receptor for human immunodeficiency virus (HIV) infection. The murine monoclonal antibody (NMb) 2D7, which recognizes a conformation-dependent epitope in the second extracellular loop of CCR5, is one of the most potent inhibitors of R5 virus cell entry. However, attempts to humanize 2D7 for in vivo human use have been unsuccessful so far.
"A filamentous phage library expressing random peptides...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.